Health Technology Assessment: A Strategic Tool for Achieving Universal Health Coverage in India
Summary
Health Technology Assessment India (HTAIN), established under the Department of Health Research following the National Health Policy 2017, has completed more than 80 studies generating evidence that has informed pricing, procurement, and adoption decisions across national health programmes — from dramatically reducing sickle cell testing costs to informing TB drug regimens and enabling cost-effective technologies like portable neonatal hearing screening and AI-assisted chest X-ray interpretation to be deployed at scale.
Key Points
- HTAIN established under the Department of Health Research following National Health Policy 2017 recommendations
- More than 80 studies completed with dozens more underway through a network of technical partners, resource centres, resource hubs, and user departments
- National Sickle Cell Elimination Mission: HTA evaluations demonstrated point-of-care tests could be procured at affordable prices, generating savings of thousands of crore rupees
- C-Tb testing for latent tuberculosis: HTA recommendations informed procurement decisions that reduced per-test costs and generated substantial savings
- Portable neonatal hearing screening devices assessed as cost-effective alternatives, adopted across multiple states
- Portable ECG machines deployed widely in primary healthcare settings for cardiovascular screening
- Telemedicine-enabled otoscopes and colour fundus photography for diabetic retinopathy screening adopted through HTA evidence
- National Tuberculosis Elimination Programme: HTA studies informed adoption of new drug regimens, digital adherence monitoring, and AI-assisted chest X-ray interpretation
- HTAIN supported revision and rationalisation of hundreds of Health Benefit Packages under government-funded health insurance schemes
- Six months of trastuzumab therapy for breast cancer evaluated as cost-effective alternative to standard 12-month regimen
Background Context
Universal Health Coverage seeks to ensure all people have access to quality health services without financial hardship. In a country as large and diverse as India, achieving UHC requires more than expanding healthcare infrastructure — it demands careful choices about which health technologies, medicines, diagnostics, devices, and interventions should be adopted, scaled, and financed. Health Technology Assessment has emerged as a critical instrument to support these decisions, systematically evaluating health technologies based on clinical effectiveness, cost-effectiveness, safety, equity implications, and ethical considerations. By generating evidence on both health outcomes and economic value, HTA enables policymakers to identify interventions that deliver the greatest health benefits within available resources.
Constitutional Articles
- Article 21 — Right to Life and Personal Liberty, interpreted to include right to health
- Article 38 — State to secure a social order for the promotion of welfare
- Article 39(e) — Protection of health and strength of workers
- Article 42 — Just and humane conditions of work and maternity relief
- Article 47 — Duty of the State to raise the level of nutrition and standard of living and to improve public health
Acts Mentioned
- National Health Policy, 2017 — framework establishing HTA as a mechanism for evidence-informed decision-making
- National Sickle Cell Elimination Mission framework
- National Tuberculosis Elimination Programme guidelines
Schemes Mentioned
- National Sickle Cell Elimination Mission — screening 7 crore people in tribal and high-prevalence areas
- National Tuberculosis Elimination Programme (NTEP)
- Ayushman Bharat — Pradhan Mantri Jan Arogya Yojana (PM-JAY) — Health Benefit Packages
- National Programme for Control of Blindness (NPCB)
Topic Understanding and Details
Health Technology Assessment Framework
- What it is: A systematic process that evaluates health technologies based on clinical effectiveness, cost-effectiveness, safety, equity implications, and ethical considerations, generating evidence to support policy, procurement, pricing, and programme implementation decisions.
- Key details:
- HTAIN established under the Department of Health Research following National Health Policy 2017 recommendations
- More than 80 studies completed with dozens more underway
- Network of technical partners, resource centres, resource hubs, and user departments across central and state governments
- Evaluations cover new health technologies, drugs, diagnostics, devices, and interventions
- Evidence generated informs both clinical efficacy and affordability considerations
- Connection to this article: HTA bridges the gap between innovation and affordability, ensuring that modern healthcare technologies — which offer significant clinical benefits but can impose substantial financial burdens — are evaluated for value relative to cost before being adopted at scale.
Sickle Cell and Tuberculosis Programmes
- What it is: The application of HTA evidence to national disease elimination programmes, demonstrating how systematic evaluation can dramatically reduce costs while enabling large-scale screening and treatment in vulnerable populations.
- Key details:
- National Sickle Cell Elimination Mission: HTA evaluations demonstrated rapid point-of-care tests could be procured at affordable prices while remaining cost-effective
- Procurement strategy reduced testing costs dramatically, estimated to generate savings of thousands of crore rupees
- C-Tb testing for latent tuberculosis: HTA recommendations reduced per-test costs and generated substantial savings for the TB programme
- National Tuberculosis Elimination Programme: HTA studies informed adoption of new drug regimens, digital adherence monitoring tools, and AI-assisted chest X-ray interpretation
- These assessments ensure programme decisions are guided not only by clinical efficacy but also by affordability and long-term sustainability
- Connection to this article: These examples demonstrate how HTA evidence directly translates into cost savings and improved programme effectiveness, enabling technologies to reach the populations that need them most.
Diagnostic and Screening Technologies
- What it is: The evaluation and adoption of innovative diagnostic and screening technologies — from portable devices to AI-assisted tools — through HTA evidence to expand access to specialised care in primary healthcare settings.
- Key details:
- Portable neonatal hearing screening devices assessed as cost-effective alternatives for early detection, adopted across multiple states
- Portable ECG machines assessed through HTA deployed widely in primary healthcare settings for cardiovascular screening
- Telemedicine-enabled otoscopes and colour fundus photography for diabetic retinopathy screening supported by HTA evidence
- These technologies expand access to specialised care particularly in resource-constrained settings
- AI-assisted chest X-ray interpretation for TB screening deployed through programme decisions informed by HTA
- Connection to this article: HTA evidence enables the deployment of innovative technologies that would otherwise remain confined to tertiary care centres, bringing specialist capabilities to primary healthcare settings across the country.
Health Financing and Insurance Coverage
- What it is: The role of HTA in informing health financing decisions, including the revision and rationalisation of Health Benefit Packages under government-funded health insurance schemes to balance clinical need with fiscal sustainability.
- Key details:
- Health Benefit Packages under Ayushman Bharat — PM-JAY must balance clinical need with fiscal sustainability
- HTAIN supported revision and rationalisation of hundreds of Health Benefit Packages
- Evidence showed six months of trastuzumab therapy for breast cancer provides adequate clinical benefit at lower cost than standard 12-month regimen
- This optimises resource allocation while maintaining quality of care
- Ensures scarce public resources are directed towards interventions that provide greatest benefit to largest number of people
- Connection to this article: HTA evidence enables evidence-informed decisions about what services to include in insurance coverage, ensuring that government-funded health schemes provide maximum value while remaining fiscally sustainable.
Equity and Access in Health Technology
- What it is: The consideration of equity implications in HTA evaluations, ensuring that health technologies address the needs of vulnerable populations including tribal communities, rural populations, and those in resource-constrained settings.
- Key details:
- National Sickle Cell Elimination Mission focuses on tribal communities in states like Madhya Pradesh, Chhattisgarh, Maharashtra, Odisha, Jharkhand, Gujarat, and Rajasthan
- Screening technologies evaluated for feasibility in remote and underserved areas without full laboratory infrastructure
- Portable and point-of-care devices assessed for deployment in primary healthcare settings
- Telemedicine-enabled technologies expand access to specialised care in rural areas
- HTA evaluations ensure equity implications are considered alongside clinical effectiveness and cost-effectiveness
- Connection to this article: HTA provides a framework for ensuring that health technology decisions are guided not just by clinical and economic considerations, but also by equity — ensuring that the benefits of innovation reach those who need them most.
Relevance for UPSC
This article is directly relevant to GS2 (government policies for health sector development) and GS3 (science and technology applications in healthcare), offering a comprehensive case study of how Health Technology Assessment serves as a strategic tool for achieving Universal Health Coverage — bridging innovation with affordability, enabling evidence-informed decisions, and ensuring equitable access to quality healthcare across India.
Constitutional articles
- Article 21 — Right to Life and Personal Liberty, interpreted to include right to health
- Article 38 — State to secure a social order for the promotion of welfare
- Article 39(e) — Protection of health and strength of workers
- Article 42 — Just and humane conditions of work and maternity relief
- Article 47 — Duty of the State to raise the level of nutrition and standard of living and to improve public health
Acts mentioned
- National Health Policy, 2017 — framework establishing HTA as a mechanism for evidence-informed decision-making
- National Sickle Cell Elimination Mission framework
- National Tuberculosis Elimination Programme guidelines
Schemes mentioned
- National Sickle Cell Elimination Mission — screening 7 crore people in tribal and high-prevalence areas
- National Tuberculosis Elimination Programme (NTEP)
- Ayushman Bharat — Pradhan Mantri Jan Arogya Yojana (PM-JAY) — Health Benefit Packages
- National Programme for Control of Blindness (NPCB)
Source: Yojana, August 2026 · Read the original ↗